Retinoid suppression of ventricular muscle cell hypertrophy
US6060311A · kind A · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 1998 |
| Grant date | May 9, 2000 |
| Priority date | — |
| Expiry date | Mar 10, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/9453
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a method of suppressing ventricular muscle cell hypertrophy induced by an .alpha..sub.1 -adrenergic agonist or endothelin, by providing an effective amount of a retinoic acid compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.